# US Traumatic Brain Injuries Treatment Market > US Traumatic Brain Injuries Treatment Market Research Report By Application (Immediate Emergency Care, Medications, Surgery), By Product Type (Diuretics, Anti-Seizure Drugs, Coma-Inducing Drugs, Anti-Anxiety Agents, Anti-Depressant, Anti-Psychotics, Analgesic, Anti-Convulsants, Anti-Coagulants, Removing Clotted Blood, Repairing Skull Fracture, Bleeding in the Brain, Opening a Window in the Skull, Rehabilitation) and By End User (Hospitals, Neurologist, Independent Pharmacies, Rehabilitative Center Treatment, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.42% - **2024:** $ 487.55 Million - **2025:** $ 523.73 Million - **2035:** $ 1,071.63 Million - **Key Players:** Medtronic (US), Johnson & Johnson (US), Stryker (US), Baxter International (US), Boston Scientific (US), NeuroPace (US), Integra LifeSciences (US), Abbott Laboratories (US) **Report ID:** MRFR/Pharma/15200-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-traumatic-brain-injuries-treatment-market-16728 --- ## Market Summary ## **US Traumatic Brain Injuries Treatment Market Overview** As per MRFR analysis, the US Traumatic Brain Injuries Treatment Market Size was estimated at 450.8 (USD Million) in 2023. The US Traumatic Brain Injuries Treatment Market Industry is expected to grow from 487.55(USD Million) in 2024 to 1,194.9 (USD Million) by 2035. The US Traumatic Brain Injuries Treatment Market CAGR (growth rate) is expected to be around 8.491% during the forecast period (2025 - 2035). ### **Key US Traumatic Brain Injuries Treatment Market Trends Highlighted** The US Traumatic Brain Injuries (TBI) Treatment Market is currently experiencing several key trends influenced by various market drivers. One significant driver is the increasing awareness and understanding of TBIs, driven by advocacy groups and educational initiatives. This heightened awareness is encouraging patients to seek timely medical intervention, thus expanding the treatment options available. Additionally, advancements in medical technology are enabling more effective treatment methods, such as improved surgical techniques and rehabilitation therapies, which are enhancing patient outcomes. Opportunities in the market are growing due to the rising incidence of TBIs, particularly in the contexts of sports, accidents, and combat-related injuries. The US military, for instance, has made addressing TBIs among veterans a top priority, leading to increased funding and research into better treatment methods. Furthermore, the aging population within the US is contributing to the demand for TBI treatments, as older adults are more susceptible to falls, which are a common cause of TBIs. Recent trends indicate an increasing focus on personalized medicine, where treatments are tailored to the individual needs of patients based on their specific conditions and responses to previous treatments. The integration of telemedicine in treating TBIs is also gaining traction, providing patients with easier access to specialists and ongoing care. Research and development are paving the way for innovative therapies, including the use of neurostimulation devices and regenerative medicine, further enhancing the treatment landscape. Overall, these trends demonstrate a shift towards more effective, patient-centered care in the US TBI treatment market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Traumatic Brain Injuries Treatment Market Drivers** ### **Increasing Incidence of Traumatic Brain Injuries** The US Traumatic Brain Injuries Treatment Market Industry is significantly influenced by the rising incidence of traumatic brain injuries (TBIs). According to the Centers for Disease Control and Prevention (CDC), approximately 1.5 million individuals sustain TBIs annually in the United States. Furthermore, an estimated 5.3 million Americans live with a disability resulting from these injuries. The adoptive measures for enhancing awareness and care for TBIs, coupled with increasing healthcare spending in the United States, are propelling the growth of the market. Prominent organizations like the Brain Injury Association of America are dedicated to providing education and resources related to TBIs, which further drives treatment advancements. Therefore, the heightened frequency of these injuries is compelling healthcare providers to develop more effective treatment solutions, thereby fostering market growth. ### **Advancements in Medical Technology** The US Traumatic Brain Injuries Treatment Market Industry is benefitting from rapid advancements in medical technology, particularly in diagnostic tools and treatment modalities. Innovations such as advanced imaging techniques, including Magnetic Resonance Imaging (MRI) and computerized tomography (CT) scans, have dramatically improved diagnosis and assessment speed and accuracy for TBIs. The American College of Radiology supports and promotes these advancements, leading to increased adoption among healthcare facilities. Also, the FDA continues to expedite the approval processes for new TBI treatments, which further reinforces market expansion as new therapies become available for patient use. ### **Growing Awareness and Education on TBI** Increasing public and professional awareness regarding traumatic brain injuries is driving growth in the US Traumatic Brain Injuries Treatment Market Industry. Campaigns led by organizations, such as the National Institute of Neurological Disorders and Stroke, aim to educate the public about the symptoms and consequences of TBIs. The National Health Service reports that public awareness of TBIs has jumped by approximately 20 percent over the past five years, evidenced by increased outreach programs and training for first responders. As more individuals recognize the symptoms of TBIs and seek timely care, the demand for effective treatments increases, consequently benefiting the market. ## **US Traumatic Brain Injuries Treatment Market Segment Insights** ### **Traumatic Brain Injuries Treatment Market Application Insights** The US **[Traumatic Brain Injuries Treatment Market](../../../reports/traumatic-brain-injuries-treatment-market-6839)** is a crucial aspect of healthcare, focusing on various applications to manage this significant public health issue. Among the primary applications of treatment are Immediate Emergency Care, Medications, and Surgery, each playing a vital role in addressing the urgent and long-term needs of patients suffering from traumatic brain injuries. Immediate Emergency Care is paramount, as quick response actions significantly improve outcomes; this segment is often the first point of contact for patients and is instrumental in stabilizing their condition before further treatment. Medications are essential for managing symptoms, reducing inflammation, and preventing complications that can arise from traumatic brain injuries, demonstrating a trend towards pharmacological advancements that target specific pathways involved in neural injury and recovery. Surgery may be necessary to alleviate pressure on the brain, repair skull fractures, or address other serious complications that can arise from severe injuries; this area shows increasing innovation in surgical techniques that improve recovery times and minimize risks. Moreover, the integration of advanced technologies, such as robotics and minimally invasive procedures, enhances the effectiveness of surgical interventions, while research into novel therapeutic drugs is expanding the possibilities in the medications space. The US Traumatic Brain Injuries Treatment Market segmentation indicates a growing emphasis on individualized care approaches, where treatment is tailored to the specific needs and conditions of the patients, aligning with broader healthcare trends advocating for personalized medicine. Given the rising incidence of traumatic brain injuries in the United States, particularly among young adults and the aging population, the market continually adapts, with healthcare providers focusing on education, prevention, and improved care methodologies to meet the evolving needs of these patients. Understanding this segment's dynamics aids in recognizing the broader implications for patient care and public health strategies in the US. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Traumatic Brain Injuries Treatment Market Product Type Insights** The US Traumatic Brain Injuries Treatment Market is largely influenced by various product types designed to address the complexities of brain injury management. Key treatment methods include Diuretics and Anti-Seizure Drugs, which are crucial in managing intracranial pressure and preventing seizures, respectively. Coma-Inducing Drugs play a significant role by promoting recovery in severe cases, while Anti-Anxiety Agents and Anti-Depressant medications help in addressing emotional and cognitive repercussions following trauma. Other treatment modalities, such as Anti-Psychotics and Analgesics, are essential for managing psychiatric symptoms and pain. In addition, Anti-Convulsants and Anti-Coagulants are vital in controlling seizure activity and preventing complications from blood clotting. Procedures such as Removing Clotted Blood and Repairing Skull Fractures are critical in addressing physical injuries, ensuring optimal outcomes for patients. Additionally, strategies like Opening a Window in the Skull are employed to alleviate pressure and enhance recovery. Rehabilitation plays an essential role by facilitating recovery and improving the quality of life for patients. Overall, these diverse treatment modalities together reflect the multifaceted approach necessary for effectively treating traumatic brain injuries in the US. ### **Traumatic Brain Injuries Treatment Market End User Insights** The End User segment of the US Traumatic Brain Injuries Treatment Market plays a critical role in delivering essential care to patients, encompassing a range of healthcare facilities and professionals, including Hospitals, Neurologists, Independent Pharmacies, Rehabilitative Center Treatment, and others. Hospitals are at the forefront, providing immediate care and advanced treatment options for traumatic brain injuries, which is crucial given the increasing prevalence of these injuries. Neurologists, specializing in diagnosing and managing neurological disorders, contribute significantly to patient outcomes and recovery strategies. Independent Pharmacies also serve as accessible points for medication management and patient education, ensuring ongoing treatment continuity. Rehabilitative Centers play a vital role in the recovery process, offering comprehensive therapies tailored to individual needs. The integration of these facilities fosters a collaborative environment focused on improving patient outcomes. Increasing awareness of traumatic brain injuries and advancements in treatment methodologies significantly bolster this segment. As the US population ages and sports-related injuries rise, the demand for effective treatment across these diverse end users is likely to increase, driving market growth and innovations in care strategies. ## **US Traumatic Brain Injuries Treatment Market Key Players and Competitive Insights** The US Traumatic Brain Injuries Treatment Market is characterized by a highly competitive landscape where companies strive to innovate and enhance their product offerings. The increasing prevalence of traumatic brain injuries, driven by factors such as sports-related incidents, road accidents, and military operations, has significantly fueled the demand for effective treatment options. Organizations are focusing on developing advanced medical devices and therapies aimed at improving patient outcomes. The market is influenced by a combination of technological advancements, regulatory guidelines, and the evolving healthcare ecosystem, which together create a dynamic environment for manufacturers and healthcare providers alike. Companies are investing in research and development to create groundbreaking solutions that address the complexities of traumatic brain injuries, tailoring their strategies to cater to an increasingly aware consumer base. Smith and Nephew stands out in the US Traumatic Brain Injuries Treatment Market due to its commitment to innovation and excellence in the medical technology field. The company has established a strong presence through its diverse range of products aimed at treating traumatic brain injuries, focusing on advanced surgical procedures and rehabilitation technologies. Smith and Nephew has built a reputation for producing high-quality medical devices, which enhance both surgical precision and patient recovery. The organization's dedication to research and development has enabled it to remain at the forefront of technological advancements, thereby reinforcing its market position. With a focus on strategic partnerships and collaborations within the healthcare sector, Smith and Nephew continues to leverage its strengths, ensuring that it remains a key player in the treatment of traumatic brain injuries across the United States. Parker Hannifin also plays a vital role in the US Traumatic Brain Injuries Treatment Market, providing essential products and technologies that contribute to improved patient care. Known for its precision components and advanced actuation systems, Parker Hannifin has developed specialized solutions tailored to enhance medical interventions in traumatic brain injury cases. Their robust portfolio includes various products that assist in surgical applications and rehabilitation processes. The company prides itself on a strong commitment to innovation, continually investing in research to enhance its offerings. Parker Hannifin's strategic acquisitions have further expanded its capabilities and capabilities, allowing it to introduce cutting-edge technologies to the market. By leveraging its extensive industry experience and a keen focus on customer needs, Parker Hannifin has solidified its reputation as a trusted partner in the healthcare industry, providing effective solutions for traumatic brain injuries while addressing the unique challenges faced within the US market. ### **Key Companies in the US Traumatic Brain Injuries Treatment Market Include** ## **US Traumatic Brain Injuries Treatment Market Industry Developments** Recent developments in the US Traumatic Brain Injuries Treatment Market reflect a heightened focus on advancements in therapeutic strategies and technologies. Notably, in recent months, companies like Johnson and Johnson and Stryker have been actively involved in collaborating with research institutions to enhance their product pipelines for innovative treatment solutions. In September 2023, Stryker announced the launch of a new surgical device aimed at improving outcomes for traumatic brain injury patients, signaling ongoing innovation in medical technology. Furthermore, in August 2023, Medtronic made headlines by acquiring a biotech firm specializing in neurostimulation technologies, aligning with the growing market for minimally invasive procedures in TBI management. The market valuation has been positively impacted by increasing government funding for brain injury research, with a reported increase of 15% in grants allocated to TBI initiatives compared to previous years. This growth is driving competition among major players, such as Boston Scientific and AstraZeneca, to expand their therapeutic offerings and capture a larger market share. Additionally, the patient advocacy and awareness programs are on the rise to address the long-term effects of traumatic brain injuries, pushing healthcare providers to improve treatment strategies effectively. ## **US Traumatic Brain Injuries Treatment Market Segmentation Insights** ### **Traumatic Brain Injuries Treatment Market Application Outlook** ### **Traumatic Brain Injuries Treatment Market Product Type Outlook** ### **Traumatic Brain Injuries Treatment Market End User Outlook** ## Market Drivers ### Advancements in Medical Technology Technological advancements in medical devices and treatment methodologies are significantly influencing the traumatic brain-injuries-treatment market. Innovations such as neuroimaging techniques, robotic-assisted surgeries, and advanced rehabilitation technologies are enhancing the precision and effectiveness of TBI treatments. For instance, the use of functional MRI and CT scans allows for better diagnosis and monitoring of brain injuries, leading to more tailored treatment plans. The market is projected to grow as these technologies become more integrated into clinical practice, with estimates suggesting a compound annual growth rate (CAGR) of around 7% over the next few years. This growth reflects the increasing reliance on technology to improve patient outcomes in TBI cases. ### Government Initiatives and Funding Government initiatives aimed at improving brain injury treatment and prevention are playing a crucial role in the traumatic brain-injuries-treatment market. Federal and state programs are increasingly allocating funds for research and development in TBI treatments, which is expected to enhance the availability of innovative therapies. For example, the National Institutes of Health (NIH) has been actively funding studies focused on understanding the mechanisms of brain injuries and developing new treatment protocols. This financial support not only fosters innovation but also encourages collaboration between academic institutions and healthcare providers, ultimately leading to improved treatment options for patients suffering from TBIs. ### Growing Focus on Rehabilitation Services The growing emphasis on rehabilitation services for TBI patients is a significant driver of the traumatic brain-injuries-treatment market. As awareness of the long-term consequences of TBIs increases, there is a corresponding rise in demand for comprehensive rehabilitation programs that address cognitive, physical, and emotional recovery. Facilities specializing in neurorehabilitation are expanding, offering tailored therapies that include physical therapy, occupational therapy, and psychological support. This trend is likely to continue, with market analysts predicting a steady increase in the rehabilitation segment, which could account for a substantial portion of the overall market revenue in the coming years. ### Increased Collaboration Among Stakeholders The traumatic brain-injuries-treatment market is witnessing increased collaboration among various stakeholders, including healthcare providers, researchers, and pharmaceutical companies. This collaboration is fostering the development of multidisciplinary approaches to TBI treatment, which may lead to more effective and holistic care for patients. Partnerships between academic institutions and industry players are particularly noteworthy, as they facilitate the translation of research findings into clinical practice. Such collaborations are expected to enhance the pipeline of new therapies and interventions, thereby driving market growth. The collective efforts of these stakeholders are likely to result in improved treatment outcomes and a more robust market landscape. ### Rising Incidence of Traumatic Brain Injuries The increasing incidence of traumatic brain injuries (TBIs) in the US is a primary driver for the traumatic brain-injuries-treatment market. According to the Centers for Disease Control and Prevention (CDC), TBIs contribute to a significant number of hospitalizations and fatalities annually. The growing awareness of the long-term effects of TBIs, such as cognitive impairments and emotional disturbances, has led to heightened demand for effective treatment options. This trend is further supported by the aging population, which is more susceptible to falls and accidents that result in TBIs. As a result, healthcare providers are focusing on developing innovative treatment modalities to address the needs of this patient demographic, thereby propelling the market forward. ## Future Outlook The [Traumatic Brain Injuries Treatment Market](https://www.marketresearchfuture.com/reports/traumatic-brain-injuries-treatment-market-6839) is projected to grow at a 7.42% CAGR from 2025 to 2035, driven by advancements in medical technology and increasing awareness. **New opportunities:** - Development of telehealth platforms for remote patient monitoring - Investment in AI-driven diagnostic tools for early detection - Expansion of rehabilitation services tailored for TBI patients By 2035, the market is expected to achieve substantial growth, reflecting evolving treatment methodologies. ## Segment Insights ### By Treatment: Surgery (Largest) vs. Medications (Fastest-Growing) In the US traumatic brain-injuries-treatment market, Surgery captures the largest market share due to its critical role in addressing severe injuries. Immediate Emergency Care follows, playing an essential part in initial response and stabilization of patients. Medications, while smaller in share, are witnessing increased adoption as part of comprehensive treatment plans for TBI patients. Growth trends indicate a significant movement towards innovative surgical techniques and minimally invasive procedures, making Surgery a dominant force. Medications are emerging rapidly, reflecting advancements in pharmacological research aimed at improving recovery outcomes. Continued focus on patient-centered care and enhanced emergency response protocols contribute to the positive outlook for all segments within the market. Surgery (Dominant) vs. Medications (Emerging) Surgery in the US traumatic brain-injuries-treatment market is characterized by its necessity in severe cases, involving procedures such as craniotomy or decompressive craniectomy. This segment is backed by advancements in surgical techniques and technology, ensuring timely and effective responses to traumatic brain injuries. On the other hand, the Medications segment represents an emerging area of growth, spotlighted by innovative treatment options that target symptoms and aid in rehabilitation. This sector is gaining traction through increasing research and development focused on optimizing medication regimens for recovery, thus complementing surgical interventions. The collaboration between surgical practices and medical treatments enhances overall patient care, illustrating a dynamic balance within the US TBI treatment landscape. ### By End-User: Hospitals (Largest) vs. Rehabilitative Center Treatment (Fastest-Growing) The distribution of the US traumatic brain-injuries-treatment market by end-user reveals that hospitals hold the largest share, providing essential emergency and surgical intervention services. Following hospitals are neurologists and independent pharmacies, which cater to specialized care and medication needs, respectively. Rehabilitative centers and other treatment facilities also play significant roles in the continuum of care for patients recovering from traumatic brain injuries, contributing to the overall market dynamics. Growth in the US traumatic brain-injuries-treatment market is driven by an increasing incidence of traumatic brain injuries, necessitating specialized treatment options. The evolution of treatment methodologies, coupled with the rising demand for rehabilitative services, positions rehabilitative center treatment as the fastest-growing segment. Additionally, advancements in medical technology and an increase in awareness regarding brain injury management further stimulate growth across all end-user segments. Hospitals (Dominant) vs. Rehabilitative Center Treatment (Emerging) Hospitals remain the dominant end-user segment in the US traumatic brain-injuries-treatment market, primarily due to their comprehensive capabilities in providing immediate medical care, surgical interventions, and post-acute services. They are equipped to handle a high influx of patients seeking emergency care. Conversely, rehabilitative center treatment is an emerging segment, reflecting a growing trend towards long-term recovery approaches. These centers focus on personalized rehabilitation plans and therapies, catering to patients post-hospitalization. The integration of innovative rehabilitation techniques and specialized staff enhances the recovery process, making this segment increasingly vital for holistic brain injury management. ## Competitive Benchmarking The traumatic brain-injuries-treatment market is characterized by a competitive landscape, driven by advancements in medical technology and an increasing focus on patient outcomes. Key players such as Medtronic (US), Johnson & Johnson (US), and Stryker (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) emphasizes innovation through its robust pipeline of neurostimulation devices, while Johnson & Johnson (US) focuses on strategic partnerships to expand its product offerings. Stryker (US) is actively pursuing mergers and acquisitions to bolster its capabilities in neurotrauma solutions, thereby shaping a competitive environment that is increasingly collaborative and innovation-driven.In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Baxter International (US) and Boston Scientific (US) is notable, as they leverage their extensive distribution networks and established reputations to maintain competitive advantages. In October Medtronic (US) announced the launch of a new neurostimulation device designed to improve recovery outcomes for traumatic brain injury patients. This strategic move underscores Medtronic's commitment to innovation and positions the company to capture a larger share of the market by addressing unmet clinical needs. The introduction of this device is likely to enhance patient care and solidify Medtronic's leadership in the sector. In September Johnson & Johnson (US) entered into a partnership with a leading research institution to develop advanced imaging technologies for brain injuries. This collaboration is significant as it not only enhances Johnson & Johnson's technological capabilities but also aligns with the growing trend of integrating digital solutions into treatment protocols. Such partnerships may facilitate the development of more effective treatment modalities, thereby improving patient outcomes. In August Stryker (US) completed the acquisition of a smaller firm specializing in innovative neurotrauma products. This acquisition is indicative of Stryker's strategy to expand its product portfolio and enhance its competitive positioning. By integrating these new technologies, Stryker is likely to strengthen its market presence and offer comprehensive solutions for traumatic brain injuries. As of November the competitive trends in the market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into treatment protocols. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This transition may ultimately lead to improved patient outcomes and a more sustainable market environment. ## Recent News & Developments Recent developments in the US Traumatic Brain Injuries Treatment Market reflect a heightened focus on advancements in therapeutic strategies and technologies. Notably, in recent months, companies like Johnson and Johnson and Stryker have been actively involved in collaborating with research institutions to enhance their product pipelines for innovative treatment solutions. In September 2023, Stryker announced the launch of a new surgical device aimed at improving outcomes for traumatic brain injury patients, signaling ongoing innovation in medical technology. Furthermore, in August 2023, Medtronic made headlines by acquiring a biotech firm specializing in neurostimulation technologies, aligning with the growing market for minimally invasive procedures in TBI management. The market valuation has been positively impacted by increasing government funding for brain injury research, with a reported increase of 15% in grants allocated to TBI initiatives compared to previous years. This growth is driving competition among major players, such as Boston Scientific and AstraZeneca, to expand their therapeutic offerings and capture a larger market share. Additionally, the patient advocacy and awareness programs are on the rise to address the long-term effects of traumatic brain injuries, pushing healthcare providers to improve treatment strategies effectively. ## Report Scope | MARKET SIZE 2024 | 487.55(USD Million) | | --- | --- | | MARKET SIZE 2025 | 523.73(USD Million) | | MARKET SIZE 2035 | 1071.63(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.42% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Stryker (US), Baxter International (US), Boston Scientific (US), NeuroPace (US), Integra LifeSciences (US), Abbott Laboratories (US) | | Segments Covered | Treatment, End-User | | Key Market Opportunities | Advancements in neurorehabilitation technologies enhance recovery pathways in the traumatic brain-injuries-treatment market. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in traumatic brain injury treatment options. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US traumatic brain-injuries-treatment market in 2024?** A: The overall market valuation was $487.55 Million in 2024. **Q: What is the projected market valuation for the US traumatic brain-injuries-treatment market by 2035?** A: The projected valuation for 2035 is $1,071.63 Million. **Q: What is the expected CAGR for the US traumatic brain-injuries-treatment market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 7.42%. **Q: Which companies are considered key players in the US traumatic brain-injuries-treatment market?** A: Key players include Medtronic, Johnson & Johnson, Stryker, Baxter International, Boston Scientific, NeuroPace, Integra LifeSciences, and Abbott Laboratories. **Q: What were the segment valuations for Immediate Emergency Care in 2024?** A: The segment valuation for Immediate Emergency Care was $146.26 Million to $320.00 Million. **Q: How much was spent on medications for traumatic brain injuries in 2024?** A: The expenditure on medications was between $97.55 Million and $210.00 Million. **Q: What was the valuation for surgery as a treatment segment in 2024?** A: The valuation for surgery as a treatment segment ranged from $243.74 Million to $541.63 Million. **Q: What are the projected segment valuations for hospitals in the US traumatic brain-injuries-treatment market?** A: The projected segment valuation for hospitals is between $150.00 Million and $350.00 Million. **Q: What is the expected valuation for rehabilitative center treatment by 2035?** A: The expected valuation for rehabilitative center treatment is projected to be between $150.00 Million and $300.00 Million. **Q: What is the market outlook for independent pharmacies in the US traumatic brain-injuries-treatment market?** A: The market outlook for independent pharmacies indicates a valuation between $50.00 Million and $100.00 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-traumatic-brain-injuries-treatment-market-16728*